Published in Proc Natl Acad Sci U S A on October 01, 1979
Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells. Nucleic Acids Res (1981) 2.42
Regulation of cell proliferation and differentiation by interferons. Biochem J (1985) 1.75
New insights into the role of RNase L in innate immunity. J Interferon Cytokine Res (2010) 1.73
Molecular cloning and sequence of partial cDNA for interferon-induced (2'-5')oligo(A) synthetase mRNA from human cells. Proc Natl Acad Sci U S A (1983) 1.73
Diverse functions of RNase L and implications in pathology. Biochimie (2007) 1.21
Abnormal behavior of interferon-induced enzymatic activities in an interferon-resistant cell line. Proc Natl Acad Sci U S A (1980) 1.14
Accumulation of newly synthesized mRNAs in response to human fibroblast (beta) interferon. Proc Natl Acad Sci U S A (1981) 1.10
Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis. Proc Natl Acad Sci U S A (1998) 0.94
Regulation of in vitro translation by double-stranded RNA in mammalian cell mRNA preparations. Nucleic Acids Res (1988) 0.92
5'-O-Monophosphoryladenylyl(2' goes to 5')adenylyl(2' goes to 5')adenosine is an antagonist of the action of 5'-O-triphosphoryladenylyl-(2' goes to 5')adenylyl(2' goes to 5')adenosine and double-stranded RNA. Proc Natl Acad Sci U S A (1981) 0.89
The interferon renaissance: molecular aspects of induction and action. Microbiol Rev (1981) 0.89
A mammalian 2-5A system functions as an antiviral pathway in transgenic plants. Proc Natl Acad Sci U S A (1996) 0.85
Intracellular immunity: finding the enemy within--how cells recognize and respond to intracellular pathogens. J Leukoc Biol (2014) 0.77
Wanderings in biochemistry. J Biol Chem (2014) 0.75
pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci U S A (1978) 5.69
Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis. Nature (1976) 3.58
Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell (1978) 3.53
Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A. Nature (1978) 2.59
Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. Proc Natl Acad Sci U S A (1978) 2.22
Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase. Proc Natl Acad Sci U S A (1978) 1.97
Interferon action: isolation of nuclease F, a translation inhibitor activated by interferon-induced (2'-5') oligo-isoadenylate. FEBS Lett (1978) 1.80
Synthesis of an oligonucleotide inhibitor of protein synthesis in rabbit reticulocyte lysates analogous to that formed in extracts from interferon-treated cells. Eur J Biochem (1978) 1.79
Interferon, double-stranded RNA and mRNA degradation. Nature (1976) 1.70
Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonucleaseINT system into two macromolecular components; role of a small molecule in nuclease activation. Biochem Biophys Res Commun (1978) 1.70
Mechanism for discrimination between viral and host mRNA in interferon-treated cells. Proc Natl Acad Sci U S A (1979) 1.57
Synthesis and breakdown of pppA2'p5'A2'p5'A and transient inhibiton of protein synthesis in extracts from interferon-treated and control cells. Eur J Biochem (1978) 1.54
Oligonucleotide inhibitor of protein synthesis made in extracts of interferon-treated chick embryo cells: comparison with the mouse low molecular weight inhibitor. Proc Natl Acad Sci U S A (1978) 1.54
Synthesis of 2'5'-oligo(A) in extracts of interferon-treated HeLa cells. J Biol Chem (1979) 1.49
Induction of 2'5'-oligoadenylate synthetase activity and a new protein by chick interferon. Virology (1979) 1.41
Increased endonuclease activity in an extract from mouse Ehrlich ascites tumor cells which had been treated with a partially purified interferon preparation: dependence of double-stranded RNA;. Biochem Biophys Res Commun (1976) 1.37
Metabolic stability of 2' 5'oligo (A) and activity of 2' 5'oligo (A)-dependent endonuclease in extracts of interferon-treated and control HeLa cells. Nucleic Acids Res (1979) 1.20
Interferon, double-stranded RNA and RNA degradation. Characteristics of an endonuclease activity. Eur J Biochem (1977) 1.14
Mechanism of interferon action. Properties of an interferon-mediated ribonucleolytic activity from mouse L929 cells. Virology (1978) 1.14
Enzymic synthesis, characterisation and nuclear-magnetic-resonance spectra of pppA2'p5'A2'p5'A and related oligonucleotides: comparison with chemically synthesised material. Eur J Biochem (1979) 1.09
Impairment of reovirus mRNA methylation in extracts of interferon-treated Ehrilich ascites tumor cells: further characteristics of the phenomenon. J Virol (1977) 1.08
2'5'Oligo(A) polymerase activity and inhibition of viral RNA synthesis in interferon-treated HeLa cells. Biochemistry (1979) 1.05
Messenger RNA methylation, translation and degradation in extracts of interferon-treated cells. Tex Rep Biol Med (1977) 0.85
Biochemistry of interferons and their actions. Annu Rev Biochem (1982) 6.89
Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol (1998) 4.07
Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature (1979) 3.43
The interferon system. A bird's eye view of its biochemistry. J Biol Chem (1992) 3.39
Interferon, double-stranded RNA, and protein phosphorylation. Proc Natl Acad Sci U S A (1976) 3.24
Mechanism of protein biosynthesis. Bacteriol Rev (1969) 2.57
Interferon action: RNA cleavage pattern of a (2'-5')oligoadenylate--dependent endonuclease. Science (1981) 2.38
Structure and expression of cloned murine IFN-alpha genes. Nucleic Acids Res (1983) 2.35
Nucleotide sequence of a ribosome attachment site of bacteriophage f2 RNA. Biochem Biophys Res Commun (1970) 2.32
Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. Proc Natl Acad Sci U S A (1978) 2.22
Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. Int J Epidemiol (2000) 2.03
Formylmethionyl-tRNA dependence of amino acid incorporation in extracts of trimethoprim-treated Escherichia coli. Science (1966) 1.98
Randomized placebo-controlled trial of 2,3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking arsenic-contaminated water. J Toxicol Clin Toxicol (2001) 1.88
On the relation between ribonucleic acid synthesis and peptide chain initiation in E. coli. Proc Natl Acad Sci U S A (1966) 1.83
Interferon, double-stranded RNA, and protein phosphorylation. Characteristics of a double-stranded RNA-activated protein kinase system partially purified from interferon treated Ehrlich ascites tumor cells. J Biol Chem (1978) 1.81
Purification and analysis of a factor which suppresses nick-induced transcription by RNA polymerase II and its identity with poly(ADP-ribose) polymerase. J Biol Chem (1983) 1.74
Interferon, double-stranded RNA and mRNA degradation. Nature (1976) 1.70
Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonucleaseINT system into two macromolecular components; role of a small molecule in nuclease activation. Biochem Biophys Res Commun (1978) 1.70
Mode of regulation of natural killer cell activity by interferon. J Exp Med (1980) 1.63
Interferons as gene activators. Cloning of the 5' terminus and the control segment of an interferon activated gene. J Biol Chem (1986) 1.53
Pregnancy outcomes, infant mortality, and arsenic in drinking water in West Bengal, India. Am J Epidemiol (2006) 1.43
Increased endonuclease activity in an extract from mouse Ehrlich ascites tumor cells which had been treated with a partially purified interferon preparation: dependence of double-stranded RNA;. Biochem Biophys Res Commun (1976) 1.37
Interferon action: two (2'-5')(A)n synthetases specified by distinct mRNAs in Ehrlich ascites tumor cells treated with interferon. Cell (1983) 1.37
Translation of in vitro synthesized reovirus messenger RNAs into proteins of the size of reovirus capsid proteins in a mouse L cell extract. Biochem Biophys Res Commun (1972) 1.33
Interferon, double-stranded RNA, and RNA degradation. Isolation of homogeneous pppA(2'p5'A)n-1 synthetase from Ehrlich ascites tumor cells. J Biol Chem (1980) 1.30
Movement of the ribosome along the messenger ribonucleic acid during protein synthesis. Biochemistry (1971) 1.30
Inhibition of protein synthesis directed by added viral and cellular messenger RNAs in extracts of interferon-treated Ehrlich ascites tumor cells. Location and dominance of the inhibitor(s). Biochem Biophys Res Commun (1973) 1.30
Mouse interferons: amino terminal amino acid sequences of various species. Science (1980) 1.30
Polynucleotide-dependent incorporation of amino acids in a cell-free system from thermophilic bacteria. J Biol Chem (1966) 1.29
Mouse interferons enhance the accumulation of a human HLA RNA and protein in transfected mouse and hamster cells. J Biol Chem (1982) 1.29
Interferons as gene activators. Indications for repeated gene duplication during the evolution of a cluster of interferon-activatable genes on murine chromosome 1. J Biol Chem (1989) 1.28
Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy. J Infect Dis (1994) 1.27
The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities. Mol Cell Biol (1996) 1.26
On the recognition of serine transfer RNA's specific for unrelated codons by the same seryl-transfer RNA synthetase. Proc Natl Acad Sci U S A (1968) 1.23
Purification of interferon from mouse Ehrlich ascites tumor cells. J Biol Chem (1978) 1.23
Interferon assay based on the inhibition of double-stranded reovirus RNA accumulation in mouse L cells. J Gen Virol (1973) 1.17
The interferon-inducible nucleolar p204 protein binds the ribosomal RNA-specific UBF1 transcription factor and inhibits ribosomal RNA transcription. EMBO J (1999) 1.17
Transcripts of human HLA gene fragments lacking the 5'-terminal region in transfected mouse cells. Proc Natl Acad Sci U S A (1984) 1.16
On three complementary amino acid polymerization factors from Bacillus stearothermophilus: separation of a complex containing two of the factors, guanosine-5'-triphosphate and aminoacyl-transfer RNA. Proc Natl Acad Sci U S A (1968) 1.15
Interferon, double-stranded RNA and RNA degradation. Characteristics of an endonuclease activity. Eur J Biochem (1977) 1.14
Cloning, sequencing, and expression of two murine 2'-5'-oligoadenylate synthetases. Structure-function relationships. J Biol Chem (1991) 1.13
Formation and characteristics of reovirus subviral particles in interferon-treated mouse L cells. Nucleic Acids Res (1976) 1.12
Interferon treatment of Ehrlich ascites tumor cells: effects on exogenous mRNA translation and tRNA inactivation in the cell extract. J Virol (1975) 1.11
Interferon action: cytoplasmic and nuclear localization of the interferon-inducible 52-kD protein that is encoded by the Ifi 200 gene from the gene 200 cluster. J Interferon Res (1993) 1.11
Peptide chain elongation: discrimination against the initiator transfer RNA by microbial amino-acid polymerization factors. Nature (1968) 1.11
Measurement of optical transport properties of normal and malignant human breast tissue. Appl Opt (2001) 1.10
Studies on the role of the 2'-5'-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication. J Virol (1988) 1.10
Cloning and expression of cDNA for human poly(ADP-ribose) polymerase. Proc Natl Acad Sci U S A (1987) 1.09
Impairment of reovirus mRNA methylation in extracts of interferon-treated Ehrilich ascites tumor cells: further characteristics of the phenomenon. J Virol (1977) 1.08
Interferon action: binding of viral RNA to the 40-kilodalton 2'-5'-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J Virol (1991) 1.08
Interferon action: transcriptional control of a gene specifying a 56,000-Da protein in Ehrlich ascites tumor cells. Virology (1985) 1.08
Peptide chain elongation. Role of the S 1 factor in the pathway from S 3 -guanosine diphosphate complex to aminoacyl transfer ribonucleic acid-S 3 -guanosine triphosphate complex. Biochemistry (1971) 1.07
Inhibition of reovirus messenger RNA methylation in extracts of interferon-treated Ehrlich ascites tumor cells. Biochem Biophys Res Commun (1975) 1.06
Peptide chain elongation. Cold Spring Harb Symp Quant Biol (1969) 1.06
Release of the inhibition of messenger RNA translation in extracts of interferon-treated Ehrlich ascites tumor cells by added transfer RNA. Biochem Biophys Res Commun (1974) 1.05
Translation of reovirus messenger ribonucleic acids synthesized in vitro into reovirus proteins in a mouse L cell extract. Arch Biochem Biophys (1973) 1.04
Toward theoretical analysis of long-range proton transfer kinetics in biomolecular pumps. J Phys Chem A (2006) 1.04
Selective inhibition of viral protein accumulation in interferon-treated cells; nondiscriminate inhibition of the translation of added viral and cellular messenger RNAs in their extracts. Virology (1974) 1.04
Inhibition of E2F-mediated transcription by p202. EMBO J (1996) 1.02
Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis. Ann Surg Oncol (2000) 1.02
Interferon action: effects of mouse alpha and beta interferons on rosette formation, phagocytosis, and surface-antigen expression of cells of the macrophage-type line RAW 309Cr.1. Cell Immunol (1982) 1.01
Apparent changes in ribosome conformation during protein synthesis. Centrifugation at high speed distorts initiation, pretranslocaton, and posttranslocation complexes to a different extent. Biochemistry (1972) 1.00
Interferon action: nucleolar and nucleoplasmic localization of the interferon-inducible 72-kD protein that is encoded by the Ifi 204 gene from the gene 200 cluster. J Cell Biol (1992) 0.99
Binding of an interferon-inducible protein (p202) to the retinoblastoma protein. J Biol Chem (1995) 0.99
Plasma prolactin as an indicator of disease progression in advanced breast cancer. Cancer (1990) 0.99
Enzymology of interferon action--a short survey. Methods Enzymol (1981) 0.97
Interferons as gene activators. Characteristics of an interferon-activatable enhancer. J Biol Chem (1987) 0.97
Characteristics of three homologous 202 genes (Ifi202a, Ifi202b, and Ifi202c) from the murine interferon-activatable gene 200 cluster. Genomics (1999) 0.96
Synthesis of (2'-5')(A)n from ATP. Characteristics of the reaction catalyzed by (2'-5')(A)n synthetase purified from mouse Ehrlich ascites tumor cells treated with interferon. J Biol Chem (1980) 0.96
Interferons, double-stranded RNA, and RNA degradation. Isolation and characterization of homogeneous human (2'-5')(a)n synthetase. J Biol Chem (1981) 0.96
Multi-class classification algorithm for optical diagnosis of oral cancer. J Photochem Photobiol B (2006) 0.96
MyoD-dependent induction during myoblast differentiation of p204, a protein also inducible by interferon. Mol Cell Biol (2000) 0.96
Developmental and TGF-beta-mediated regulation of Ank mRNA expression in cartilage and bone. Osteoarthritis Cartilage (2002) 0.95
PKR: proposed nomenclature for the RNA-dependent protein kinase induced by interferon. J Interferon Res (1993) 0.95
Inhibition of peptide-chain initiation in Escherichia coli by hydroxylamine and effects on ribonucleic acid synthesis. Biochemistry (1970) 0.95
Peptide chain elongation: GTP cleavage catalysed by factors binding aminoacyl-transfer RNA to the ribosome. Nature (1969) 0.95
Ectopic production of prolactin by colorectal adenocarcinoma. Dis Colon Rectum (2001) 0.94
Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma. Dis Colon Rectum (2001) 0.94
Stoichiometry of aminoacyl-transfer RNA binding and GTP cleavage during chain elongation and translocation. Nature (1969) 0.94
Neutral sphingomyelinase from human urine. Purification and preparation of monospecific antibodies. J Biol Chem (1989) 0.94
Ribosome formation from subunits: dependence on formylmethionyl-transfer RNA in extracts from E. coli. Nature (1968) 0.94
beta-Interferon alters the pattern of proteins secreted from quiescent and platelet-derived growth factor-treated BALB/c-3T3 cells. J Biol Chem (1985) 0.94
Increase in p202 expression during skeletal muscle differentiation: inhibition of MyoD protein expression and activity by p202. Mol Cell Biol (1998) 0.92
Identification of cell surface receptors for murine macrophage inflammatory protein-1 alpha. J Immunol (1991) 0.92
Mueller matrix approach for determination of optical rotation in chiral turbid media in backscattering geometry. Opt Express (2006) 0.91
Prolactin as a local growth promoter in patients with breast cancer: GCRI experience. Eur J Surg Oncol (2000) 0.91
Comparison of postsurgical and community acquired bacterial meningitis--analysis of 372 cases within a nationwide survey. Neuro Endocrinol Lett (2007) 0.91